GLP-1 Patients Quit Then Return, New Study Reveals

Cost, availability and medical process are big issues with these medications. A lot of the stopping is not side effects or completion its a broken healthcare system. They don't track their own failures and why patients are forced to stop these treatments that aren't their choice. The fact 60% restart later on shows a lot of the external factors are involved and people didn't abandon treatment.
 
Back
Top